Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Not sure how to tackle the task of writing about your intervention? IHIP can help.News Article updated on 01/27/2023
-
A Celebration of our 2022 CQII Quality Award Winners
A presentation by two 2022 CQII Quality Award Winners: Santa Rosa Community Health Centers and Dallas County Health and Human Services HIV Administrative Agency.Resource updated 08/17/2023
-
HIV Clinical Pharmacist Services
The HIV Clinical Pharmacist Services intervention shortens the time between referral to and engagement in care by allowing newly referred clients to see pharmacists in addition to other clinical providers for their initial appointment. This intervention is supported by findings from a retrospective cohort study that took place from 2013 to 2017 at a RWHAP-funded clinic. In addition to significantly decreasing the time between referral and initial visit, clients who saw a pharmacist also experienced shortened time to antiretroviral therapy initiation and viral suppression compared to those who only saw non-pharmacist providers.Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
-
Mpox Emergency is Over
The mpox emergency declaration ended at the end of January 2023.News Article updated on 02/02/2023 -
Tax Filings and Health Coverage: The Relationship
Taxes and health coverage are connected in two important ways: providing proof of health coverage when required; reconciling under- or over-paid premium tax credits.Blog updated 02/28/2023
-
Project nGage
Project nGage is a support intervention approach that offers participants an initial 90-minute session with a social work interventionist and a participant support confidant to develop a tailored care and support plan. The social work interventionist then offers four follow-up sessions to each participant to discuss progress on the care and support plan. Project nGage was evaluated in a randomized controlled trial from 2012 to 2015: participants in the intervention were more likely to have at least three HIV primary care visits in the last 12 months than those who received usual care.Resource from the RWHAP Best Practices Compilation updated on 11/30/2023
-
Division of State HIV/AIDS Programs: RWC 2022 Business Day Meeting
HRSA's HIV/AIDS Bureau's Division of State HIV/AIDS Programs (DSHAP) session for recipients focused on the Ending the HIV Epidemic, how to conduct remote subrecipient site visits, and succession planning.Resource (Conference Presentation) updated 09/14/2023
-
Division of Metropolitan HIV/AIDS Programs: RWC 2022 Business Day Meeting
HRSA's HIV/AIDS Bureau's Division of Metropolitan HIV/AIDS Programs (DMHAP) session for recipients focused on using data and approaches to Ending the HIV Epidemic.Resource (Conference Presentation) updated 09/14/2023
-
Division of Policy and Data: RWC 2022 Business Day Meeting
DPD session for recipients, focused on technical assistance and policy resources, with breakouts on evaluation and implementation science, health disparities, and data coordination.Resource (Conference Presentation) updated 09/14/2023
-
Office of Program Support: RWC 2022 Business Day Meeting
HRSA's HIV/AIDS Bureau's Office of Program Support (OPS) session for recipients, focused on the AIDS Education and Training Center (AETC) Program.Resource (Conference Presentation) updated 09/14/2023
-
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Collecting and Using Data to Inform and Improve Information Dissemination
The TargetHIV website is the central hub for RWHAP technical assistance (TA), with an audience of 40,000 unique users a year. Of these, approximately 25 percent access resources from data-related TA providers. This poster will describe how we collect and interpret website data to monitor and improve our dissemination approaches.
Resource (Conference Presentation) updated 09/14/2023
-
Attitudes Towards Rapid Start of Antiretroviral Therapy in New Jersey
Review of data on delivery of rapid start of ART among New Jersey providers, including, for example, provision of same-day medical appointments, extended office hours, and comfort administering rapid start with high need patients.
Resource (Conference Presentation) updated 12/11/2023
-
The Max Clinic
The Max Clinic, located within the University of Washington’s Harborview Medical Center complex in Seattle, offers walk-in services and incentives to clients reengaging in HIV care, especially those who have not been well served by the traditional health care model—including clients who are experiencing homelessness, or who have mental health and substance use issues. The Max Clinic offers rapid antiretroviral therapy, incentives, a flexible clinical model, and access to comprehensive support services. Max Clinic clients were significantly more likely to reach viral suppression after 12 months than a comparable control group.Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
-
Improving Time to Antiretroviral Therapy Initiation in Newly Diagnosed PLWH in a Nonurban Clinic
Review of rapid ART features to reduce time to ART from 7 to 1.6 days, including pre-visit benefits navigation, manufacturer discount cards, prescribing to in-house pharmacies, email distribution lists, and post-prescriptive follow-up.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
Get READI! Outcomes from 2 years of rapid ART services at a county hospital system
Harris Health System began its Rapid Eligibility and ART Dissemination & Implementation (READI) program in 2019. Here, we present two years of data that examine linkage to care, ART initiation, viral loads, completion of medical visits, and demographics for patients who received READI services and those who did not.
Resource (Conference Presentation) updated 09/14/2023
-
Special Session: Ryan White's Story, as Told by His Mother, Jeanne White-Ginder
Ryan White's story, as told by his mother, Jeanne White-Ginder. Hear about Ryan's personal struggles, his ability to rise above those barriers, and how he became a national spokesperson - forever changing the public's perception of AIDS.
Resource (Conference Presentation) updated 09/14/2023
-
Plenary: Opening Remarks for the 2022 National Ryan White Conference (Laura Cheever)
HRSA's HIV/AIDS Bureau Associate Administrator Dr. Laura Cheever, opened the conference with a review of the history of the RWHAP, which recently recognized the 32nd anniversary of the Ryan White CARE Act on August 18, 1990.Resource (Conference Presentation) updated 09/14/2023